Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis

Published:2024 Issue:5 Volume:65 Page:423
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Lee Kunwoo¹^ORCID,Yu Jiwoong²^ORCID,Song Wan²^ORCID,Sung Hyun Hwan²^ORCID,Jeon Hwang Gyun²^ORCID,Jeong Byong Chang²^ORCID,Seo Seong Il²^ORCID,Jeon Seong Soo²^ORCID,Kang Minyong²³⁴^ORCID

Affiliation:

1. Inha University College of Medicine, Incheon, Korea.

2. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.

4. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.

Funder

Korean Urological Association

Korea Health Industry Development Institute

Publisher

XMLink

Link

https://icurology.org/pdf/10.4111/icu.20240052

Reference45 articles.

1. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

2. Systemic Therapy for Metastatic Renal-Cell Carcinoma

3. Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma

4. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

5. CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP